Podcast 610 – “Beyond the Medical Model for Psychedelics”

Support Lorenzo on Patreon.com Guest speakers: Annie Oak and Ismail Ali PROGRAM NOTES: Date this lecture was recorded: February 26, 2019. Thanks to the new wave of research, psychedelics are poised to soon have legal medical use. MDMA- and psilocybin-assisted therapy are entering their final trials with “breakthrough therapy” designation by the FDA. But what’s […]

Podcast 606 – “Michael Pollan Discusses Psychedelics”

Support Lorenzo on Patreon.com Guest speaker: Michael Pollan PROGRAM NOTES: Date this lecture was recorded: June 6, 2018 Today’s program features an interview with Michael Pollan by Michael Margolies from the Psychedelic Seminars project in San Francisco. Pollan is the author of seven previous books which were all New York Times bestsellers. In 2010, TIME […]

Podcast 605 – “Microdosing: Benefits, Risks, Unknowns”

Support Lorenzo on Patreon.com Guest speakers: James Fadiman and Ayelet Waldman PROGRAM NOTES: Date this interview was recorded: October 22, 2018. Today’s podcast centers around microdosing psychedelics, LSD in particular. Much of today’s interest in microdosing psychedelics blossomed after the publication of The Psychedelic Explorer’s Guide, which was written by Dr. James Fadiman, who has […]

Podcast 603 – “Treating Opioid Addiction with Ibogaine”

Support Lorenzo on Patreon.com Guest speakers: Andrew Tatarsky and Lakshmi Narayan PROGRAM NOTES: Date this lecture was recorded: April 22, 2019 Today’s podcast features a recording of a recent session of the Psychedelic Salon LIVE in which our guests were Dr. Andrew Tatarsky and Lakshmi Narayan. In an interactive conversation with several of our fellow […]

PREVIEW of Podcast 590

Support Lorenzo on Patreon.com Guest speaker: Terence McKenna PROGRAM NOTES: Date this lecture was recorded: June 24, 1989. Today we continue with a workshop that Terence McKenna led at the Esalen Institute in June of 1989. Although he begins with an exploration of ideas surrounding the use of sound during psychedelic experiences, he also tells […]

Podcast 588 – “Good News on the Psychedelic Front” – Pt. 2

Support Lorenzo on Patreon.com Guest speaker: Rick Doblin PROGRAM NOTES: Date this lecture was recorded: August 31, 2018.] Today we continue with the second part of the 2018 Palenque Norte Lecture given by Rick Doblin, the president of the Multidisciplinary Association for Psychedelic Studies. In addition to learning some new information about the current state […]

Podcast 587 – “Good News on the Psychedelic Front” – Pt. 1

Support Lorenzo on Patreon.com Guest speaker: Rick Doblin PROGRAM NOTES: Date this lecture was recorded: August 31, 2018. Today’s podcast features the 2018 Palenque Norte Lecture given by Rick Doblin, the president of MAPS. In addition to a detailed description of the interaction between MAPS and the Veterans Administration, Rick also gives a detailed account […]

Podcast 585 – “Psychedelic Clinics In Our Future”

Support Lorenzo on Patreon.com Guest speaker: Will Siu PROGRAM NOTES: Date this lecture was recorded: August 29, 2018.] Today’s podcast features Dr. Will Siu, an MD and psychiatrist specializing, among other things, in ketamine-assisted psychotherapy. Dr. Siu is also one of the participating researchers in the MAPS MDMA study. In this 2018 Palenque Norte Lecture, […]

Podcast 555 – “Drug Policy”

Follow Lorenzo on Patreon.com Guest speaker: John Gilmore PROGRAM NOTES: Date this lecture was recorded: September 1, 2017 [NOTE: All quotations are by John Gilmore] “The U.S. still has the world’s largest prison population in absolute numbers and per capita. We imprison more people than the next ten countries put together. It’s insane. It’s a […]

Podcast 550 – “FDA Approved Phase 3 MDMA/PTSD Research”

Guest speaker: Rick Doblin PROGRAM NOTES: Date this lecture was recorded: September 1, 2017 Today we feature the 2017 Palenque Norte Lecture delivered by the founder of the Multidisciplinary Association of Psychedelic Studies, Rick Doblin. In this wide ranging talk, besides an update about the recent FDA approval for MAPS’ major Phase 3 study of […]